Found a bug or want a feature? Verified reports earn free credits.
Log inSign up
Companies›Healthcare›Healthcare›Pharmaceuticals & Biotechnology

AURO LABORATORIES LTD.

Healthcare › Pharmaceuticals & Biotechnology
₹233.90
at close · 27 Oct 2026
▲ 2.90 (+1.26%)

Latest filings

  1. Quarterly dematerialization certificate filed with BSE for Q2 FY27 · Compliance
  2. Trading Window Closed from Oct 1 for Q2 FY26 Results · Compliance
  3. Newspaper publication of Q1 FY27 unaudited financial results · Compliance
All filings ↓
Ask Nexa about AURO LABORATORIES LTD.

Snapshot

What the business is, and whether it's a good one at a fair price.

A Pharmaceuticals & Biotechnology company listed on BSE, reporting revenue of ₹31 Cr over the trailing twelve months.

Market Cap
₹146 Cr
P / E (TTM)
41.3×
EV / EBITDA
17.5×
Div Yield
—
Growth
-10.7%▼
Revenue 5y CAGR
PAT -13.2% · EBITDA -0.2%
Quality
11.3%·
ROCE (5y median)
ROE 7.6% (5y median) · margin 38.6%
Leverage
1.37·
Debt / Equity · moderate
Net debt ₹62 Cr
Revenue FY21→FY26
0.6×▼
Margin −1.7 pts
₹54 Cr → ₹31 Cr
Cash conversion
1.27×▲
Operating cash ÷ profit · 5 yrs
₹23 Cr on ₹18 Cr
Moves on a normal day
1.60%·
Median daily move
Last 267 sessions · the yardstick for filing-day moves
Where it sits among 185 Pharmaceuticals peersBar = share of peers beaten · tick = industry median · latest reported figures
P/E (TTM)#107/158
P/B#88/163
ROCE#122/183
ROE#102/166
Debt / Equity#158/166
EBITDA margin#10/165
Revenue growth#42/161
Profit growth#30/158

Scorecard

Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice

Strengths
Over 5 years it reported ₹18 Cr of profit and ₹23 Cr of operating cash — 1.27×
Profit is converting into cash
Concerns
Revenue shrinking over 5 years (−11% a year)
Profit shrinking over 5 years (−13% a year)
Erratic profits — up in only 2 of the last 5 years
Carries more debt than its peers — 1.37× equity
higher than 95% of its 166 Pharmaceuticals peers
Heavy working capital — 214 days of cash tied up
Customers are taking longer to pay — 49 → 109 days of receivables
FY21 → FY26

Charts

How has the market priced it — with filings on the timeline?

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from AURO LABORATORIES LTD.'s filed financials and exchange disclosures

What does AURO LABORATORIES LTD. do?

AURO LABORATORIES LTD. is a Pharmaceuticals & Biotechnology company listed on BSE.

Is AURO LABORATORIES LTD. profitable?

Yes. Over the trailing twelve months AURO LABORATORIES LTD. reported a net profit of ₹3.53 Cr on revenue of ₹31 Cr.

Does AURO LABORATORIES LTD. pay a dividend?

Not in the latest reported year — AURO LABORATORIES LTD.'s dividend payout for FY26 was nil.

Is AURO LABORATORIES LTD. debt-free?

No. It reported borrowings of ₹63 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹62 Cr after cash. Debt stands at 1.37× equity. That is higher than 95% of its 166 Pharmaceuticals peers.

Is AURO LABORATORIES LTD. expensive compared with its peers?

On trailing P/E, AURO LABORATORIES LTD. ranks 107 of 158 in Pharmaceuticals — cheaper than 33% of them, against an industry median of 30.1×. This is a position, not a valuation judgement.

How much does the AURO LABORATORIES LTD. share price move in a day?

On a typical session AURO LABORATORIES LTD. moves 1.60% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.

Where can I track AURO LABORATORIES LTD.'s announcements?

Every NSE and BSE filing by AURO LABORATORIES LTD. appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.